CT or MRI?
The researchers focused on CT scans rather than MRIs because the 3D information is richer, with better spatial resolution in all three planes. “We have been able to adapt the technique to work with MRI, but this has mainly focused on 3D mapping of cartilage thickness at the knee, which MRI is far better at visualizing,” Dr. Turmezei says. “It is still important to consider [CT] joint space mapping as complementary to other imaging techniques such as MRI, which has its own strengths over CT, such as the ability to depict soft tissues such as cartilage and ligaments as well as inflammation.” CT does better show mineralized structures, such as bone.
You Might Also Like
Explore This IssueNovember 2018
Also By This Author
As MRI techniques develop, however, a similar 3D joint space mapping approach will likely become possible with clinical MRI data. Dr. Turmezei’s PhD thesis in 2017 showed it was feasible, but the sequences needed to do it are not in everyday clinical use. “One of the great strengths of CT joint space mapping is that it uses regular CT imaging data that can be acquired on any hospital scanner right now,” he says.
Prior to joining together, two of the researchers had already been collaborating for a few years, using cortical bone mapping to investigate thickness changes in the diagnosis and treatment of osteoporosis. With his background in radiology, Dr. Turmezei was able to bring a new set of clinical problems around osteoarthritis imaging for the team to solve.
Because his PhD was in the engineering department, Dr. Turmezei says he had to learn advanced math and coding to develop and validate the algorithm, and that experience brought him skills he continues to use in his research and clinical practice.
“I feel very lucky to have worked with and between these research groups that continue to be committed to solving clinical problems with novel engineering solutions,” he says. “The keystone to the success of these collaborations is the ability to identify meaningful clinical problems that need a solution. Otherwise time is wasted on developing tools that don’t have any relevant clinical utility.”